Neuro-osteoarthropathy of the Foot—Radiologist: Friend or Foe?

ABSTRACT

Charcot neuro-osteoarthropathy is a significant problem with a rapid devastating nature. If not recognized it may lead to progressive foot deformity, ulceration or osteomyelitis, or eventually to amputation. The diagnosis is challenging, and imaging plays a pivotal role. Rapid and accurate diagnosis and early intervention is important to prevent progressive and destructive Charcot deformity of the foot.

The imaging workup of the warm swollen Charcot foot is presented. The advantages and disadvantages of different imaging modalities are discussed. This review provides the consulting radiologists with tools to cautiously differentiate Charcot's neuro-osteoarthropathy from osteomyelitis. It is crucial to look beyond radiological features and integrate the location of pathology and presence of ulcer in the reading process. Because imaging plays a pivotal role in arriving at the definitive diagnosis and adequate treatment, the radiologist “makes the difference”—can be a friend or a foe.

KEYWORDS

Charcot - neuro-osteoarthropathy - osteomyelitis - foot - imaging - diabetes

REFERENCES

• 1 Lavery L A, Armstrong D G, Wunderlich R P, Tredwell J, Boulton A J. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort.  Diabetes Care. 2003;  26(5) 1435-1438
• 2 Smith D G, Barnes B C, Sands A K, Boyko E J, Ahroni J H. Prevalence of radiographic foot abnormalities in patients with diabetes.  Foot Ankle Int. 1997;  18(6) 342-346
• 3 Nabarro J D. Diabetes in the United Kingdom: a personal series.  Diabet Med. 1991;  8(1) 59-68
• 4 Holewski J J, Moss K M, Stess R M, Graf P M, Grunfeld C. Prevalence of foot pathology and lower extremity complications in a diabetic outpatient clinic.  J Rehabil Res Dev. 1989;  26(3) 35-44
• 5 Sinha S, Munichoodappa C S, Kozak G P. Neuro-arthropathy (Charcot joints) in diabetes mellitus (clinical study of 101 cases).  Medicine (Baltimore). 1972;  51(3) 191-210
• 6 Armstrong D G, Todd W F, Lavery L A, Harkless L B, Bushman T R. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic.  Diabet Med. 1997;  14(5) 357-363
• 7 Parkhouse N, Le Quesne P M. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions.  N Engl J Med. 1988;  318(20) 1306-1309
• 8 Sanders L Y, Frykberg R G. Charcot joint. In: Levin ME, O'Neal LW, Bowker JH The Diabetic Foot 2nd ed. St. Louis, MO; Mosby 1993
• 9 Onvlee G J. The Charcot Foot. A Critical Review and an Observational Study of a Group of 60 Patients [thesis]. Leiden, The Netherlands; University of Leiden 1998
• 10 Sanders L JFR. Charcot neuroarthropathy of the foot. In: Levin ME, O'Neal LW, Bowker JH, Pfiefer MA The Diabetic Foot. 6th ed. St. Louis, MO; Mosby 2001: 439-465
• 11 Gazis A, Pound N, Macfarlane R, Treece K, Game F, Jeffcoate W. Mortality in patients with diabetic neuropathic osteoarthropathy (Charcot foot).  Diabet Med. 2004;  21(11) 1243-1246
• 12 Sohn M W, Lee T A, Stuck R M, Frykberg R G, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone.  Diabetes Care. 2009;  32(5) 816-821
• 13 Dahmen R, De Jong B A, Lankhorst G J, Michels R PJ. Charcot foot in diabetes mellitus: a study on the relation between impairment and disability.  J Rehabil Sci. 1995;  8 46-50
• 14 Schon L C, Easley M E, Weinfeld S B. Charcot neuroarthropathy of the foot and ankle.  Clin Orthop Relat Res. 1998;  (349) 116-131
• 15 Caputo G M, Ulbrecht J, Cavanagh P R, Juliano P. The Charcot foot in diabetes: six key points.  Am Fam Physician. 1998;  57(11) 2705-2710
• 16 Petrova N L, Moniz C, Elias D A, Buxton-Thomas M, Bates M, Edmonds M E. Is there a systemic inflammatory response in the acute Charcot foot?.  Diabetes Care. 2007;  30(4) 997-998
• 17 Clouse M E, Gramm H F, Legg M, Flood T. Diabetic osteoarthropathy. Clinical and roentgenographic observations in 90 cases.  Am J Roentgenol Radium Ther Nucl Med. 1974;  121(1) 22-34
• 18 Apelqvist J, Bakker K, van Houtum W H, Schaper N C. International Working Group on the Diabetic Foot (IWGDF) Editorial Board . Practical guidelines on the management and prevention of the diabetic foot: based upon the International Consensus on the Diabetic Foot (2007) prepared by the International Working Group on the Diabetic Foot.  Diabetes Metab Res Rev. 2008;  24(suppl 1) S181-S187
• 19 Lipsky B A, Pecoraro R E, Wheat L J. The diabetic foot. Soft tissue and bone infection.  Infect Dis Clin North Am. 1990;  4(3) 409-432
• 20 Beltran J, Campanini D S, Knight C, McCalla M. The diabetic foot: magnetic resonance imaging evaluation.  Skeletal Radiol. 1990;  19(1) 37-41
• 21 Ledermann H P, Morrison W B, Schweitzer M E. Pedal abscesses in patients suspected of having pedal osteomyelitis: analysis with MR imaging.  Radiology. 2002;  224(3) 649-655
• 22 Ahmadi M E, Morrison W B, Carrino J A, Schweitzer M E, Raikin S M, Ledermann H P. Neuropathic arthropathy of the foot with and without superimposed osteomyelitis: MR imaging characteristics.  Radiology. 2006;  238(2) 622-631
• 23 Grayson M L, Gibbons G W, Balogh K, Levin E, Karchmer A W. Probing to bone in infected pedal ulcers. A clinical sign of underlying osteomyelitis in diabetic patients.  JAMA. 1995;  273(9) 721-723
• 24 Morrison W B, Schweitzer M E, Batte W G, Radack D P, Russel K M. Osteomyelitis of the foot: relative importance of primary and secondary MR imaging signs.  Radiology. 1998;  207(3) 625-632
• 25 Morrison W B, Schweitzer M E, Bock G W et al.. Diagnosis of osteomyelitis: utility of fat-suppressed contrast-enhanced MR imaging.  Radiology. 1993;  189(1) 251-257
• 26 Cavanagh P R, Young M J, Adams J E, Vickers K L, Boulton A J. Radiographic abnormalities in the feet of patients with diabetic neuropathy.  Diabetes Care. 1994;  17(3) 201-209
• 27 Eichenholtz S. Charcot Joints. Springfield, IL; Charles Thomas 1966
• 28 Shibata T, Tada K, Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy.  J Bone Joint Surg Am. 1990;  72(5) 749-756
• 29 Yu G V, Hudson J R. Evaluation and treatment of stage 0 Charcot's neuroarthropathy of the foot and ankle.  J Am Podiatr Med Assoc. 2002;  92(4) 210-220
• 30 Sella E J, Barrette C. Staging of Charcot neuroarthropathy along the medial column of the foot in the diabetic patient.  J Foot Ankle Surg. 1999;  38(1) 34-40
• 31 Sammak B, Abd El Bagi M, Al Shahed M et al.. Osteomyelitis: a review of currently used imaging techniques.  Eur Radiol. 1999;  9(5) 894-900
• 32 Sella E J. Current concepts review: diagnostic imaging of the diabetic foot.  Foot Ankle Int. 2009;  30(6) 568-576
• 33 Dinh M T, Abad C L, Safdar N. Diagnostic accuracy of the physical examination and imaging tests for osteomyelitis underlying diabetic foot ulcers: meta-analysis.  Clin Infect Dis. 2008;  47(4) 519-527
• 34 Chatha D S, Cunningham P M, Schweitzer M E. MR imaging of the diabetic foot: diagnostic challenges.  Radiol Clin North Am. 2005;  43(4) 747-759
• 35 Ledermann H P, Morrison W B, Schweitzer M E, Raikin S M. Tendon involvement in pedal infection: MR analysis of frequency, distribution, and spread of infection.  AJR Am J Roentgenol. 2002;  179(4) 939-947
• 36 Marcus C D, Ladam-Marcus V J, Leone J, Malgrange D, Bonnet-Gausserand F M, Menanteau B P. MR imaging of osteomyelitis and neuropathic osteoarthropathy in the feet of diabetics.  Radiographics. 1996;  16(6) 1337-1348
• 37 Miller T T, Randolph Jr D A, Staron R B, Feldman F, Cushin S. Fat-suppressed MRI of musculoskeletal infection: fast T2-weighted techniques versus gadolinium-enhanced T1-weighted images.  Skeletal Radiol. 1997;  26(11) 654-658
• 38 Petrova N L, Edmonds M E. Charcot neuro-osteoarthropathy—current standards.  Diabetes Metab Res Rev. 2008;  24(suppl 1) S58-S61
• 39 Yu J S. Diabetic foot and neuroarthropathy: magnetic resonance imaging evaluation.  Top Magn Reson Imaging. 1998;  9(5) 295-310
• 40 Croll S D, Nicholas G G, Osborne M A, Wasser T E, Jones S. Role of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections.  J Vasc Surg. 1996;  24(2) 266-270
• 41 Wang A, Weinstein D, Greenfield L et al.. MRI and diabetic foot infections.  Magn Reson Imaging. 1990;  8(6) 805-809
• 42 Weinstein D, Wang A, Chambers R, Stewart C A, Motz H A. Evaluation of magnetic resonance imaging in the diagnosis of osteomyelitis in diabetic foot infections.  Foot Ankle. 1993;  14(1) 18-22
• 43 Ledermann H P, Morrison W B, Schweitzer M E. MR image analysis of pedal osteomyelitis: distribution, patterns of spread, and frequency of associated ulceration and septic arthritis.  Radiology. 2002;  223(3) 747-755
• 44 Levine S E, Neagle C E, Esterhai J L, Wright D G, Dalinka M K. Magnetic resonance imaging for the diagnosis of osteomyelitis in the diabetic patient with a foot ulcer.  Foot Ankle Int. 1994;  15(3) 151-156
• 45 Morrison W B, Schweitzer M E, Wapner K L, Hecht P J, Gannon F H, Behm W R. Osteomyelitis in feet of diabetics: clinical accuracy, surgical utility, and cost-effectiveness of MR imaging.  Radiology. 1995;  196(2) 557-564
• 46 Nigro N D, Bartynski W S, Grossman S J, Kruljac S. Clinical impact of magnetic resonance imaging in foot osteomyelitis.  J Am Podiatr Med Assoc. 1992;  82(12) 603-615
• 47 Moore T E, Yuh W T, Kathol M H, el-Khoury G Y, Corson J D. Abnormalities of the foot in patients with diabetes mellitus: findings on MR imaging.  AJR Am J Roentgenol. 1991;  157(4) 813-816
• 48 Tomas M B, Patel M, Marwin S E, Palestro C J. The diabetic foot.  Br J Radiol. 2000;  73(868) 443-450
• 49 Morrison W B, Ledermann H P, Schweitzer M E. MR imaging of the diabetic foot.  Magn Reson Imaging Clin N Am. 2001;  9(3) 603-613 xi
• 50 Berendt A R, Peters E J, Bakker K et al.. Specific guidelines for treatment of diabetic foot osteomyelitis.  Diabetes Metab Res Rev. 2008;  24(suppl 1) S190-S191
• 51 Schweitzer M E, Morrison W B. MR imaging of the diabetic foot.  Radiol Clin North Am. 2004;  42(1) 61-71 vi
• 52 Morrison W B, Ledermann H P, Schweitzer M E. MR imaging of inflammatory conditions of the ankle and foot.  Magn Reson Imaging Clin N Am. 2001;  9(3) 615-637 xi-xii xi-xii
• 53 Boutin R D, Brossmann J, Sartoris D J, Reilly D, Resnick D. Update on imaging of orthopedic infections.  Orthop Clin North Am. 1998;  29(1) 41-66
• 54 Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture.  Diabet Med. 2005;  22(12) 1707-1712
• 55 Amital H, Applbaum Y H, Bar-On H, Rubinow A. Inside a Charcot joint.  Isr Med Assoc J. 2003;  5(6) 458-459
• 56 Gold R H, Tong D J, Crim J R, Seeger L L. Imaging the diabetic foot.  Skeletal Radiol. 1995;  24(8) 563-571
• 57 Berquist T H, Brown M L, Fitzgerald Jr R H, May G R. Magnetic resonance imaging: application in musculoskeletal infection.  Magn Reson Imaging. 1985;  3(3) 219-230
• 58 Keenan A M, Tindel N L, Alavi A. Diagnosis of pedal osteomyelitis in diabetic patients using current scintigraphic techniques.  Arch Intern Med. 1989;  149(10) 2262-2266
• 59 Palestro C J, Mehta H H, Patel M et al.. Marrow versus infection in the Charcot joint: indium-111 leukocyte and technetium-99m sulfur colloid scintigraphy.  J Nucl Med. 1998;  39(2) 346-350
• 60 Alazraki N, Dries D, Datz F, Lawrence P, Greenberg E, Taylor Jr A. Value of a 24-hour image (four-phase bone scan) in assessing osteomyelitis in patients with peripheral vascular disease.  J Nucl Med. 1985;  26(7) 711-717
• 61 Capriotti G, Chianelli M, Signore A. Nuclear medicine imaging of diabetic foot infection: results of meta-analysis.  Nucl Med Commun. 2006;  27(10) 757-764
• 62 Keidar Z, Militianu D, Melamed E, Bar-Shalom R, Israel O. The diabetic foot: initial experience with 18F-FDG PET/CT.  J Nucl Med. 2005;  46(3) 444-449
• 63 Basu S, Chryssikos T, Houseni M et al.. Potential role of FDG PET in the setting of diabetic neuro-osteoarthropathy: can it differentiate uncomplicated Charcot's neuroarthropathy from osteomyelitis and soft-tissue infection?.  Nucl Med Commun. 2007;  28(6) 465-472
• 64 Schwegler B, Stumpe K D, Weishaupt D et al.. Unsuspected osteomyelitis is frequent in persistent diabetic foot ulcer and better diagnosed by MRI than by 18F-FDG PET or 99mTc-MOAB.  J Intern Med. 2008;  263(1) 99-106